牛叉诊股

[{"date":"2026.10.16","stock":"1.17","trade":"-0.03","ind":"0.24"},{"date":"2026.10.15","stock":"-1.72","trade":"-1.39","ind":"-1.59"},{"date":"2026.10.14","stock":"0.00","trade":"-1.41","ind":"-0.88"},{"date":"2026.10.13","stock":"-1.53","trade":"-0.78","ind":"0.10"},{"date":"2026.10.12","stock":"-1.67","trade":"-2.33","ind":"-0.43"},{"date":"2026.10.09","stock":"0.72","trade":"1.57","ind":"0.05"},{"date":"2026.10.08","stock":"0.56","trade":"-1.77","ind":"-0.79"},{"date":"2026.09.30","stock":"2.05","trade":"2.11","ind":"0.31"},{"date":"2026.09.29","stock":"-1.06","trade":"0.13","ind":"0.18"},{"date":"2026.09.28","stock":"-0.16","trade":"-0.49","ind":"-1.67"},{"date":"2026.09.24","stock":"-2.22","trade":"-2.45","ind":"-1.22"},{"date":"2026.09.23","stock":"-0.86","trade":"-0.73","ind":"-0.39"},{"date":"2026.09.22","stock":"-0.78","trade":"0.53","ind":"0.06"},{"date":"2026.09.21","stock":"2.15","trade":"4.67","ind":"0.97"},{"date":"2026.09.18","stock":"0.08","trade":"0.73","ind":"0.94"},{"date":"2026.09.17","stock":"1.05","trade":"1.11","ind":"-0.41"},{"date":"2026.09.16","stock":"-0.64","trade":"0.58","ind":"0.71"},{"date":"2026.09.15","stock":"-0.48","trade":"-1.55","ind":"-0.54"},{"date":"2026.09.14","stock":"1.78","trade":"1.85","ind":"-0.07"},{"date":"2026.09.11","stock":"-1.75","trade":"-2.37","ind":"-1.18"},{"date":"2026.09.10","stock":"-2.71","trade":"-1.85","ind":"-0.43"}]

浙江医药,上证指数,化学制药指数

压力支撑

该股压力位为12.16元，支撑位为11.92元。

[{"text":"\u538b\u529b\u4f4d","value":"12.16","date":1792080000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"11.92","date":1792080000,"color":"0x0b52a1"}]

多空趋势

空头行情中，并且有加速下跌的趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.1资金面打败了37%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：10月16日 20:30

机构今日流向(万元)	-1130.70	机构5日流向(万元)	-5571.05
机构10日流向(万元)	-6378.23	机构20日流向(万元)	-11215.52

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量减少308.88万股，其中基金净增仓22家，主力净增仓26家，请投资者中长期谨慎为宜。

截止2026-06-30，共158家主力机构（基金153家，QFII1家，一般法人4家），持仓量总计46416.96万股，占流通A股48.79%
其中，基金持仓与2025-12-31相比：
增仓：48家，增持 856.38万股
减仓：26家，减持 1314.73万股
新出现在主力名单中：78家，持有1198.6万股
从主力名单中消失：52家，原持有670.03万股

消息面诊股

诊断结果：5.5消息面打败了49%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	分红转增	不分配不转增	2026-08-26
一般消息	募资投向	公司购买资产	2026-05-28
一般消息	股东大会	年度股东大会	2026-04-24
利好	分红转增	10派2.80元(含税)	2026-04-11
一般消息	募资投向	公司购买资产	2026-04-08
一般消息	募资投向	公司购买资产	2026-03-31
一般消息	募资投向	公司出售资产	2026-03-04

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：6.2行业面打败了84%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2026.10.16","price":"0.24","value":"-0.03"},{"date":"2026.10.15","price":"-1.59","value":"-1.39"},{"date":"2026.10.14","price":"-0.88","value":"-1.41"},{"date":"2026.10.13","price":"0.10","value":"-0.78"},{"date":"2026.10.12","price":"-0.43","value":"-2.33"},{"date":"2026.10.09","price":"0.05","value":"1.57"},{"date":"2026.10.08","price":"-0.79","value":"-1.77"},{"date":"2026.09.30","price":"0.31","value":"2.11"},{"date":"2026.09.29","price":"0.18","value":"0.13"},{"date":"2026.09.28","price":"-1.67","value":"-0.49"},{"date":"2026.09.24","price":"-1.22","value":"-2.45"},{"date":"2026.09.23","price":"-0.39","value":"-0.73"},{"date":"2026.09.22","price":"0.06","value":"0.53"},{"date":"2026.09.21","price":"0.97","value":"4.67"},{"date":"2026.09.18","price":"0.94","value":"0.73"},{"date":"2026.09.17","price":"-0.41","value":"1.11"},{"date":"2026.09.16","price":"0.71","value":"0.58"},{"date":"2026.09.15","price":"-0.54","value":"-1.55"},{"date":"2026.09.14","price":"-0.07","value":"1.85"},{"date":"2026.09.11","price":"-1.18","value":"-2.37"},{"date":"2026.09.10","price":"-0.43","value":"-1.85"}]

上证指数,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	莱美药业	90.06%	78.24%	6.0分
2	灵康药业	35.16%	2.73%	5.5分
3	向日葵	31.27%	18.18%	5.6分
4	华北制药	20.85%	3.81%	5.7分
5	金石亚药	19.60%	-7.50%	5.4分
6	键凯科技	16.03%	-17.74%	4.8分
7	迪哲医药	15.12%	4.42%	5.7分
8	西点药业	14.86%	8.32%	5.5分
9	海翔药业	13.44%	-6.49%	5.1分
10	-	11.23%	-2.64%	分
11	奥赛康	9.37%	-4.65%	5.9分
12	民生健康	8.81%	-3.61%	6.3分
13	恒瑞医药	8.62%	-0.47%	5.9分
14	健康元	7.81%	-0.49%	6.1分
15	健友股份	7.38%	-0.37%	5.6分
16	翰宇药业	7.23%	5.15%	6.9分
17	普洛药业	6.50%	-7.80%	5.9分
18	威尔药业	6.47%	-5.79%	5.2分
19	丽珠集团	6.35%	-5.19%	5.8分
20	华海药业	6.24%	-5.39%	5.7分
21	拓新药业	5.95%	-3.58%	4.9分
22	莎普爱思	5.94%	3.31%	5.0分
23	复星医药	5.03%	-3.81%	5.9分
24	华仁药业	4.61%	-10.88%	4.2分
25	新华制药	4.34%	-7.49%	5.3分
26	海欣股份	3.82%	11.25%	5.0分
27	石药创新	3.45%	-2.86%	5.7分
28	吉贝尔	3.31%	-2.43%	5.3分
29	亨迪药业	3.01%	-8.86%	5.1分
30	华纳药厂	2.90%	-7.91%	3.8分
31	华润双鹤	2.18%	-0.43%	6.0分
32	九典制药	1.89%	-3.83%	5.1分
33	-	1.85%	-2.40%	分
34	共同药业	1.75%	-5.78%	5.1分
35	ST人福	1.67%	-1.77%	5.6分
36	新天地	1.41%	-6.69%	5.7分
37	东诚药业	1.20%	-8.86%	5.8分
38	北陆药业	1.11%	-10.70%	5.0分
39	百济神州	0.90%	2.63%	4.9分
40	富士莱	0.87%	-5.33%	5.5分
41	福安药业	0.77%	-2.98%	5.7分
42	海森药业	0.25%	-8.22%	5.7分
43	仙琚制药	0.23%	-1.26%	5.9分
44	天宇股份	0.00%	-5.82%	5.7分
45	华东医药	-0.08%	-3.81%	5.8分
46	科伦药业	-0.47%	0.58%	5.2分
47	誉衡药业	-0.56%	-4.34%	4.7分
48	天新药业	-0.62%	-1.85%	5.5分
49	信立泰	-0.64%	-0.29%	6.1分
50	宣泰医药	-0.79%	-11.43%	4.6分
51	东北制药	-0.83%	-2.85%	5.4分
52	赛托生物	-0.83%	-6.17%	5.6分
53	罗欣药业	-0.87%	-6.95%	5.2分
54	宏辉果蔬	-0.87%	-4.32%	4.5分
55	-	-0.88%	-9.36%	分
56	德展健康	-0.89%	2.15%	5.2分
57	国药现代	-0.95%	-2.12%	4.9分
58	鲁抗医药	-1.03%	-7.00%	5.5分
59	-	-1.20%	-9.22%	分
60	国邦医药	-1.25%	-8.49%	4.3分
61	广济药业	-1.53%	-3.74%	5.2分
62	力生制药	-1.58%	-3.86%	5.1分
63	亚虹医药	-1.58%	-7.35%	3.7分
64	仟源医药	-1.60%	-7.11%	5.9分
65	中关村	-1.80%	-5.01%	4.6分
66	北大医药	-1.82%	-5.11%	5.4分
67	奥翔药业	-1.82%	-7.57%	4.6分
68	山河药辅	-1.94%	-6.72%	5.1分
69	复旦张江	-1.96%	-10.29%	4.6分
70	恩华药业	-1.97%	-1.47%	5.3分
71	本立科技	-2.02%	-4.83%	5.6分
72	首药控股	-2.03%	-10.48%	3.4分
73	华邦健康	-2.24%	-4.60%	5.6分
74	卫信康	-2.34%	-4.47%	5.3分
75	ST诺泰	-2.36%	-3.17%	4.3分
76	苑东生物	-2.45%	-1.73%	4.3分
77	汇宇制药	-2.52%	-8.61%	3.7分
78	华特达因	-2.87%	0.78%	5.4分
79	辰欣药业	-2.91%	-6.95%	4.8分
80	-	-2.96%	-3.21%	分
81	同和药业	-3.04%	-6.42%	5.5分
82	亿帆医药	-3.07%	-5.07%	5.4分
83	奥锐特	-3.33%	-7.29%	4.9分
84	京新药业	-3.42%	-4.97%	5.3分
85	浙江医药	-3.43%	-3.73%	4.7分
86	悦康药业	-3.46%	-8.22%	4.4分
87	盟科药业	-3.62%	-11.69%	3.8分
88	汉商集团	-3.69%	-4.55%	5.1分
89	新和成	-3.76%	-1.66%	6.2分
90	金陵药业	-3.77%	-4.20%	5.4分
91	金城医药	-3.88%	-10.01%	5.3分
92	凯因科技	-3.90%	-10.04%	4.5分
93	海正药业	-3.94%	-8.21%	5.2分
94	福元医药	-3.95%	-6.64%	5.1分
95	ST天圣	-4.28%	-6.37%	4.4分
96	立方制药	-4.61%	-6.65%	6.0分
97	尔康制药	-4.66%	-8.63%	5.0分
98	百利天恒	-4.79%	1.98%	4.3分
99	-	-5.07%	-5.84%	分
100	海普瑞	-5.09%	-5.76%	5.8分
101	千红制药	-5.15%	-3.99%	5.2分
102	诚意药业	-5.37%	-5.23%	5.0分
103	司太立	-5.41%	-7.68%	4.6分
104	津药药业	-5.42%	-13.76%	5.2分
105	纳微科技	-5.56%	-7.71%	4.3分
106	舒泰神	-5.86%	-8.33%	4.8分
107	神奇制药	-5.88%	-8.14%	4.5分
108	海创药业	-6.03%	-11.69%	4.3分
109	ST南新	-6.38%	-3.90%	4.3分
110	联环药业	-6.50%	-13.45%	5.3分
111	哈三联	-6.61%	-13.56%	5.4分
112	小方制药	-6.62%	-7.72%	4.3分
113	润都股份	-6.80%	-17.14%	5.3分
114	兴齐眼药	-6.85%	-5.46%	5.2分
115	海辰药业	-6.98%	-17.24%	4.7分
116	丰原药业	-7.20%	-5.84%	5.0分
117	多瑞医药	-7.23%	-9.64%	4.5分
118	川宁生物	-7.28%	-3.89%	5.0分
119	-	-7.32%	-7.02%	分
120	ST惠程	-7.53%	-4.71%	4.5分
121	双鹭药业	-7.84%	-8.16%	4.5分
122	易明医药	-7.91%	-7.81%	4.8分
123	中哲精化	-8.04%	-3.87%	5.1分
124	赛分科技	-8.73%	-13.63%	4.6分
125	东亚药业	-8.74%	-20.29%	3.6分
126	溢多利	-8.86%	-5.64%	4.6分
127	贝达药业	-8.91%	-13.24%	5.0分
128	亚太药业	-8.94%	-6.14%	4.1分
129	ST能特	-8.96%	-3.94%	4.8分
130	泰恩康	-9.08%	-6.37%	5.2分
131	海思科	-9.30%	-6.95%	6.2分
132	宏源药业	-9.75%	-11.70%	5.3分
133	广生堂	-9.84%	-1.80%	4.0分
134	美诺华	-9.86%	-16.17%	4.8分
135	昂利康	-10.13%	-6.68%	5.2分
136	一品红	-10.16%	-7.66%	4.6分
137	ST复华	-10.22%	-10.80%	4.2分
138	石药景峰	-10.24%	-6.81%	4.4分
139	上海谊众	-10.85%	-4.70%	3.8分
140	微芯生物	-11.02%	-10.32%	3.8分
141	泽璟制药	-11.04%	-7.28%	4.4分
142	通化金马	-11.23%	-4.94%	4.9分
143	哈药股份	-11.36%	-14.48%	4.6分
144	海南海药	-11.90%	-10.40%	3.9分
145	花园生物	-12.03%	-10.17%	3.6分
146	冀衡医药	-12.36%	-8.59%	4.0分
147	常山药业	-12.88%	-10.25%	3.8分
148	必贝特	-13.91%	-9.28%	4.2分
149	永安药业	-14.23%	-10.99%	5.2分
150	博瑞医药	-14.42%	-7.81%	3.9分
151	科源制药	-14.57%	-11.64%	5.0分
152	前沿生物	-14.94%	-13.44%	4.2分
153	益方生物	-16.22%	-10.54%	3.4分
154	艾力斯	-20.36%	-0.86%	4.1分
155	康芝药业	-22.34%	-6.92%	4.9分
156	富祥股份	-28.08%	-22.03%	4.3分
157	圣诺生物	-31.67%	-13.59%	4.2分
158	-	-	-6.12%	分
159	-	-	-4.34%	分

<上一页 1 2 3 4 5...27 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.1基本面打败了63%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（72.5分）

基本面得分最高的股票

[ 截止日期：2026-06-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 38/217 ， 100/217。

[{"date":"2026-06-30","value":"5.36","vol":"-0.11"},{"date":"2026-03-31","value":"2.59","vol":"0.46"},{"date":"2025-12-31","value":"8.09","vol":"-1.74"},{"date":"2025-09-30","value":"8.60","vol":"1.58"},{"date":"2025-06-30","value":"6.16","vol":"1.29"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
净资产收益率(%)	5.36	2.59	8.09	8.60	6.16
行业(%)	-0.11	0.46	-1.74	1.58	1.29

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"37.15","vol":"49.56"},{"date":"2026-03-31","value":"35.06","vol":"50.37"},{"date":"2025-12-31","value":"34.67","vol":"49.72"},{"date":"2025-09-30","value":"37.49","vol":"49.19"},{"date":"2025-06-30","value":"39.82","vol":"49.45"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
销售毛利率(%)	37.15	35.06	34.67	37.49	39.82
行业(%)	49.56	50.37	49.72	49.19	49.45

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 73/217 ， 85/217。

[{"date":"2026-06-30","value":"1.46","vol":"20.25"},{"date":"2026-03-31","value":"-2.86","vol":"24.03"},{"date":"2025-12-31","value":"-5.28","vol":"38.08"},{"date":"2025-09-30","value":"-5.87","vol":"140.73"},{"date":"2025-06-30","value":"-1.87","vol":"78.18"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
营业收入同比增长率(%)	1.46	-2.86	-5.28	-5.87	-1.87
行业(%)	20.25	24.03	38.08	140.73	78.18

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"-9.99","vol":"366.18"},{"date":"2026-03-31","value":"-29.84","vol":"51.69"},{"date":"2025-12-31","value":"-24.74","vol":"-24.28"},{"date":"2025-09-30","value":"9.83","vol":"3.38"},{"date":"2025-06-30","value":"113.52","vol":"65.15"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
净利润同比增长率(%)	-9.99	-29.84	-24.74	9.83	113.52
行业(%)	366.18	51.69	-24.28	3.38	65.15

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 27/217 ， 46/217。

[{"date":"2026-06-30","value":"0.30","vol":"0.21"},{"date":"2026-03-31","value":"0.15","vol":"0.10"},{"date":"2025-12-31","value":"0.64","vol":"0.41"},{"date":"2025-09-30","value":"0.48","vol":"0.30"},{"date":"2025-06-30","value":"0.31","vol":"0.21"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
总资产周转率(次)	0.30	0.15	0.64	0.48	0.31
行业(次)	0.21	0.10	0.41	0.30	0.21

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"1.41","vol":"1.27"},{"date":"2026-03-31","value":"0.78","vol":"0.65"},{"date":"2025-12-31","value":"2.91","vol":"2.57"},{"date":"2025-09-30","value":"2.03","vol":"1.93"},{"date":"2025-06-30","value":"1.20","vol":"1.29"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
存货增长率(次)	1.41	0.78	2.91	2.03	1.20
行业(次)	1.27	0.65	2.57	1.93	1.29

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 79/217 ， 72/217。

[{"date":"2026-06-30","value":"16.04","vol":"4.77"},{"date":"2026-03-31","value":"4.57","vol":"-2.17"},{"date":"2025-12-31","value":"18.17","vol":"16.33"},{"date":"2025-09-30","value":"29.10","vol":"4.90"},{"date":"2025-06-30","value":"23.86","vol":"2.94"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
现金流量净额/营业收入	16.04	4.57	18.17	29.10	23.86
行业	4.77	-2.17	16.33	4.90	2.94

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.77","vol":"1.32"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.56","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.54","vol":"1.72"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
资本支出／折旧和摊销	0.77	-	0.56	-	0.54
行业	1.32	0.00	1.60	0.00	1.72

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 113/217 ， 111/217。

[{"date":"2026-06-30","value":"4.10","vol":"3.55"},{"date":"2026-03-31","value":"3.39","vol":"3.57"},{"date":"2025-12-31","value":"2.96","vol":"3.38"},{"date":"2025-09-30","value":"2.79","vol":"3.46"},{"date":"2025-06-30","value":"2.98","vol":"3.72"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
流动比率	4.10	3.39	2.96	2.79	2.98
行业	3.55	3.57	3.38	3.46	3.72

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"2.96","vol":"2.85"},{"date":"2026-03-31","value":"2.44","vol":"2.93"},{"date":"2025-12-31","value":"2.13","vol":"2.75"},{"date":"2025-09-30","value":"1.95","vol":"2.72"},{"date":"2025-06-30","value":"2.00","vol":"2.93"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
速动比率	2.96	2.44	2.13	1.95	2.00
行业	2.85	2.93	2.75	2.72	2.93

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 108/217 ， 109/217。

[{"date":"2026-06-30","value":"18.48","vol":"33.40"},{"date":"2026-03-31","value":"19.84","vol":"33.15"},{"date":"2025-12-31","value":"21.30","vol":"34.33"},{"date":"2025-09-30","value":"20.69","vol":"33.76"},{"date":"2025-06-30","value":"19.80","vol":"33.99"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
资产负债率(%)	18.48	19.84	21.30	20.69	19.80
行业(%)	33.40	33.15	34.33	33.76	33.99

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-06-30","value":"0.24","vol":"0.71"},{"date":"2026-03-31","value":"0.25","vol":"9.70"},{"date":"2025-12-31","value":"0.27","vol":"1.75"},{"date":"2025-09-30","value":"0.26","vol":"1.18"},{"date":"2025-06-30","value":"0.25","vol":"0.87"}]

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
产权比率 (%)	0.24	0.25	0.27	0.26	0.25
行业(%)	0.71	9.70	1.75	1.18	0.87

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
长城证券	2026-09-08	买入
东北证券	2026-08-31	增持

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"5.40","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.30","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"11.61","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.73","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"10.84","blueLineValue":"1.13","type":"YC"}]

[浙江医药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]